SLC1A2 and stroke disorder: [37] Although ceftriaxone increased GLT-1 activity, it did not lead to a significant improvement in clinical outcomes for stroke patients; thus, it would be interesting to investigate whether Emodin’s ability to increase GLT-1 expression and the resultant decrease in extracellular glutamate could lead to significant neuroprotection in stroke patients.